Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 134 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: In vitro Diagnostic Clear all

Conditions: Influenza
Interventions: fluID Rapid Influenza Test, BinaxNOW® Influenza A & B; Device
Lead sponsor: Nanogen, Inc.; Industry
Eligibility: Not listed
Enrollment: 650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 2
States / cities: Shreveport, Louisiana • Milwaukee, Wisconsin

Conditions: Bone Marrow Suppression, Brain and Central Nervous System Tumors, Drug/Agent Toxicity by Tissue/Organ
Interventions: filgrastim, gene therapy, lomustine, procarbazine hydrochloride, vincristine sulfate, in vitro-treated peripheral blood stem cell transplantation; Procedure · Biological · Drug
Lead sponsor: Indiana University; Other
Eligibility: 5 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2011
U.S. locations: 2
States / cities: Indianapolis, Indiana • Boston, Massachusetts

Conditions: Urine Detectable Acute and Chronic Diseases
Interventions: Dip Home-Based Dipstick Analyzer, Urine analysis predicate device for professional user; Diagnostic Test · Device
Lead sponsor: Healthy.io Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 429 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 3
States / cities: Atlanta, Georgia • Methuen, Massachusetts • Garden City, New York

Conditions: Urine Detectable Acute and Chronic Diseases
Interventions: Experimental: Dip Home-Based Dipstick Analyzer; Device
Lead sponsor: Healthy.io Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 3
States / cities: Atlanta, Georgia • Methuen, Massachusetts • Garden City, New York

Conditions: Influenza
Interventions: fluID Rapid Influenza Test; Device
Lead sponsor: Nanogen, Inc.; Industry
Eligibility: Not listed
Enrollment: 1,300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 12
States / cities: San Diego, California • DeLand, Florida • Shreveport, Louisiana + 8 more

Conditions: B-Cell Lymphoproliferative Disorder
Interventions: IdentiClone Dx IGH (IC IGH Dx) Assay; Diagnostic Test
Lead sponsor: Invivoscribe, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Breast Neoplasm
Interventions: ExoPred; Diagnostic Test
Lead sponsor: EXoPERT; Industry
Eligibility: 40 Years and older · Female only
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Liver Diseases, Healthy, Liver Cirrhosis, Liver Fibrosis
Interventions: Adult; Diagnostic Test
Lead sponsor: Group K Diagnostics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Preimplantation Gentic Screening (PGS), In Vitro Fertilization (IVF), Preimplantation Genetic Diagnosis (PGD)
Interventions: 24 Chromosome Aneuploidy Screening with Parental Support; Device
Lead sponsor: Natera, Inc.; Industry
Eligibility: 35 Years to 42 Years · Female only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 9
States / cities: Laguna Hills, California • Washington D.C., District of Columbia • Clearwater, Florida + 6 more

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia
Interventions: Antitumor Drug Screening Assay, Dasatinib, Idelalisib, Laboratory Biomarker Analysis, Pacritinib, Pharmacological Study, Ponatinib, Ponatinib Hydrochloride, Ruxolitinib, Sorafenib, Sorafenib Tosylate, Sunitinib, Sunitinib Malate; Other · Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer, Pancreatic Neoplasms, Pancreas Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Recurrent, Non-Small Cell Squamous Lung Cancer, NSCLC, NSCLC, Recurrent, Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, CRC, Colorectal Cancer Metastatic, Cancer
Interventions: A2B530, xT-Onco with HLA-LOH Assay; Biological · Diagnostic Test
Lead sponsor: A2 Biotherapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 8
States / cities: Gilbert, Arizona • La Jolla, California • Los Angeles, California + 5 more

Conditions: Pneumonia, Methicillin-Resistant Staphylococcus Aureus
Interventions: Polymerase Chain Reaction (PCR); Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Multiple Myeloma
Interventions: Blood draws; Procedure
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Sexually Transmitted Diseases
Interventions: Visby Medical Men's STI PCR Test Kit; Diagnostic Test
Lead sponsor: Visby Medical; Industry
Eligibility: 14 Years and older · Male only
Enrollment: 507 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 5
States / cities: Fort Lauderdale, Florida • Miami Lakes, Florida • Atlanta, Georgia + 2 more

Conditions: Peripheral Artery Disease
Interventions: Ivus (Intravascular Ultrasound) of Amputation Specimens, IVUS (Intravascular Ultrasound); Other · Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Streptococcal Sore Throat
Interventions: Not listed
Lead sponsor: IQuum, Inc.; Industry
Eligibility: 3 Years and older
Enrollment: 799 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 5
States / cities: Norwich, Connecticut • Savannah, Georgia • Rochester, New York + 2 more

Conditions: Androgenetic Alopecia
Interventions: 5% minoxidil topical foam; Drug
Lead sponsor: Applied Biology, Inc.; Industry
Eligibility: 18 Years to 49 Years · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Tucson, Arizona • Nashville, Tennessee

Conditions: Lyme Disease
Interventions: Borrelia Diagnostic Test; Device
Lead sponsor: Advanced Laboratory Services, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 16
States / cities: Georgetown, Delaware • Rockport, Maine • Springfield, Massachusetts + 13 more

Conditions: Covid19
Interventions: CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test; Diagnostic Test
Lead sponsor: Texas Cardiac Arrhythmia Research Foundation; Other
Eligibility: Not listed
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Vitamin D Deficiency, Vitamin D Insufficiency, Healthy Volunteers
Interventions: ALPCO 25(OH) Vitamin D CLIA Kit; Device
Lead sponsor: American Laboratory Products Company; Industry
Eligibility: 22 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Salem, New Hampshire

Conditions: Thromboembolic Events
Interventions: Not listed
Lead sponsor: dsm-firmenich Switzerland AG; Industry
Eligibility: Not listed
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Cystic Fibrosis, Fungal Infection, Allergic Bronchopulmonary Aspergillosis
Interventions: Not listed
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 8 Years to 25 Years
Enrollment: 24 participants
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Highlands Ranch, Colorado

Conditions: Chronic Lymphoproliferative Diseases (CLPD)
Interventions: IUO CLPD Limited Panel; Diagnostic Test
Lead sponsor: Becton, Dickinson and Company; Industry
Eligibility: 22 Years and older
Enrollment: 371 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • San Antonio, Texas

Conditions: Hematology, Hematologic Test
Interventions: Hematology Analyzer - OLO, Hematology Analyzer - Predicate; Device
Lead sponsor: Sight Diagnostics; Industry
Eligibility: 3 Months and older
Enrollment: 679 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

A Comparative, Controlled Study to Evaluate the Lay User Accuracy and Performance of the Dip Home-Based Dipstick Analyzer

Dip Home-Based Dipstick Analyzer Performance Evaluation

Prospective Evaluation of the Fluid Rapid Influenza Test

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function Tests

Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer

Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression

Trial of MRSA Polymerase Chain Reaction for Pneumonia

Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro

Clinical Evaluation of Visby Medical Men's Sexual Health Test

Clinical Implications of Peripheral Plaque Morphology

In Vitro Diagnostic Device for the Detection of Strep A

Minoxidil Response Testing in Males With Androgenetic Alopecia

A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease

ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings

ALPCO 25(OH) Vitamin D CLIA Kit - Fresh Versus Frozen Serum and Plasma Stability Study

Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device

Immune Profiles in CF Fungal Infection

Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer

Analytical and Clinical Performance Testing Plan